EBON, DOX & SHRMF Looming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Psychedelics Investing
Titan Medical Receives License Fee of $10 Million Upon Achievement of Milestone Under Medtronic Development Agreement Medical Device Investing
Jamieson Wellness Inc. Announces Voting Results from 2021 Annual and Special Meeting of Shareholders Pharmaceutical Investing
Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service Properties Trust to Join S&P SmallCap 600 Pharmaceutical Investing
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Braxia Scientific Corp. f/k/a Champignon Brands Inc. Investors to Secure Counsel Before Important June 9 Deadline in Securities Class Action - SHRMF Psychedelics Investing
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Zeposia® , an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis1 Biotech Investing
HempFusion CBD and Probulin Probiotics Partner with Two-Time Olympic Gold Medalist and Five-Time World Champion, Kaillie Humphries Biotech Investing
Canbud Distribution Enters into Letter of Intent to Acquire Molecular Science Corp. Agriculture Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
